Bridgeway Capital Management, LLC Scynexis Inc Transaction History
Bridgeway Capital Management, LLC
- $3.98 Billion
- Q2 2025
A detailed history of Bridgeway Capital Management, LLC transactions in Scynexis Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 368,180 shares of SCYX stock, worth $305,589. This represents 0.01% of its overall portfolio holdings.
Number of Shares
368,180
Previous 353,491
4.16%
Holding current value
$305,589
Previous $335,000
26.57%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding SCYX
# of Institutions
45Shares Held
11.8MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA2.9MShares$2.4 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.86 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.38 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$1.02 Million0.22% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$461,1100.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $27.1M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...